Scientists investigated whether fibroblast growth factor 21 (FGF21) was involved in the therapeutic effect of sulforaphane against non-alcoholic fatty liver disease.
[Acta Pharmacologica Sinica]
7992332
{7992332:CCCCCCCC}
apa
50
1
167855
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
